Human papillomavirus in cervical cancer and oropharyngeal cancer: One cause, two diseases
Top Cited Papers
- 27 March 2017
- Vol. 123 (12), 2219-2229
- https://doi.org/10.1002/cncr.30588
Abstract
Human papillomavirus (HPV) causes greater than 5% of cancers worldwide, including all cervical cancers and an alarmingly increasing proportion of oropharyngeal cancers (OPCs). Despite markedly reduced cervical cancer incidence in industrialized nations with organized screening programs, cervical cancer remains the second most common cause of death from cancer in women worldwide, as developing countries lack resources for universal, high-quality screening. In the United States, HPV-related OPC is only 1 of 5 cancers with a rising incidence since 1975 and now has taken over the cervix as the most common site of HPV-related cancer. Similar trends follow throughout North America and Europe. The need for early detection and prevention is paramount. Despite the common etiologic role of HPV in the development of cervical cancer and HPV-associated OPC, great disparity exists between incidence, screening modalities (or lack thereof), treatment, and prevention in these 2 very distinct cohorts. These differences in cervical cancer and HPV-associated OPC and their impact are discussed here. Cancer 2017;123:2219-2229. © 2017 American Cancer Society.Keywords
This publication has 70 references indexed in Scilit:
- Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK populationBMC Cancer, 2013
- A Review of Clinical Trials of Human Papillomavirus Prophylactic VaccinesVaccine, 2012
- Prevalent Serum Antibody Is Not a Marker of Immune Protection against Acquisition of Oncogenic HPV16 in MenCancer Research, 2012
- The known unknowns of HPV natural historyJCI Insight, 2011
- The role of HPV in head and neck cancer and review of the HPV vaccinePreventive Medicine, 2011
- HPV-associated Oropharyngeal Cancers—Are They Preventable?Cancer Prevention Research, 2011
- Effect of Pap Smear Collection and Carrageenan on Cervicovaginal Human Papillomavirus-16 Infection in a Rhesus Macaque ModelJNCI Journal of the National Cancer Institute, 2011
- Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)Head & Neck Oncology, 2010
- Tobacco Use in Human Papillomavirus–Positive Advanced Oropharynx Cancer Patients Related to Increased Risk of Distant Metastases and Tumor RecurrenceClinical Cancer Research, 2010
- Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortiumInternational Journal of Epidemiology, 2009